ARK Invest Announces Primary Listing Venue Changes For ARK Genomic Revolution

ARK Investment Management LLC (ARK or ARK Invest), a New York-based investment adviser focused solely on disruptive innovation in the public equity markets, announced plans to change the primary listing venue of the ARK Genomic Revolution ETF (ARKG) and the ARK Autonomous Technology & Robotics ETF (ARKQ) from the NYSE Arca, Inc. to the Cboe BZX Exchange, Inc. ARK anticipates that ARKG and ARKQ will begin trading on the Cboe BZX Exchange, Inc. under their current ticker symbols on December 31, 2019. No shareholder action is required as a result of this change.

ARK's full suite of seven exchange traded funds (ETFs) also includes two additional ETFs listed on the Cboe BZX Exchange, The 3D Printing ETF (PRNT) and as well as three ETFs that remain on the NYSE Arca, the ARK Innovation ETF (ARKK), the ARK Next Generation Internet ETF (ARKW), and ARK Fintech Innovation ETF (ARKF). Each fund seeks to identify large-scale investment opportunities resulting from technologically enabled disruptive innovation. As of November 30, 2019, ARK's ETFs had approximately $3.1 billion assets under management (AUM).

"Through our exchange traded funds, ARK seeks to provide investors of all sizes a liquid and cost-efficient vehicle to access long-term growth," says Tom Staudt, ARK's Chief Operating Officer. "We believe that the companies in our strategies are creating and benefitting from the most exciting growth opportunities in the economy, but do not represent a significant weight in most portfolios."

Since launching its first funds in 2014, ARK now provides investment management services across four continents, including North America, Asia, Australia, and Europe. The firm offers a range of investment vehicles including ETFs, institutional and retail separately managed accounts, US and international mutual funds, and a UCITS fund. As of November 30, 2019, ARK's AUM was approximately $11.1 billion,1 an indication that ARK's active approach to investing and focus on disruptive innovation is unique to the industry and driving its success. ARK most recently launched the ARK Fintech Innovation ETF (ARKF) in February 2019 and made its full suite of actively managed ETFs available in Canada with its partner Emerge Canada Inc. Listed on the NEO Exchange, the Funds include: Emerge ARK Global Disruptive Innovation ETF (EARK), Emerge ARK Genomics & Biotech ETF (EAGB), Emerge ARK Fintech Innovation ETF (EAFT), Emerge ARK AI & Big Data ETF (EAAI), and the Emerge ARK Autonomous Tech & Robotics ETF (EAUT).